Thus, the upregulation of hepatic KISS1/KISS1R and plasma KP in NAFL and/or NASH may serve as a compensatory response that could slow down or resolve the progression of NAFLD. This evidence concerns the gene KISS1 and metabolic dysfunction-associated steatotic liver disease.